https://ir.nasuspharma.com/events/zacks-life-sciences-investor-forum/ 2026-08-19T14:23:44+00:00 https://ir.nasuspharma.com/events/virtual-key-opinion-leader-event-to-discuss-ns002-for-the-treatment-of-anaphylaxis/ 2026-09-08T11:26:16+00:00 https://ir.nasuspharma.com/events/nasus-pharma-marks-nyse-american-listing-with-bell-ringing-ceremony/ 2026-09-08T12:14:04+00:00 https://ir.nasuspharma.com/events/biotech-resurgence-platforms-and-pipelines-of-todays-innovators/ 2026-09-22T12:26:39+00:00 https://ir.nasuspharma.com/events/nasus-pharma-presented-clinical-results-of-intranasal-epinephrine-in-eaaci/ 2026-09-22T12:28:58+00:00 https://ir.nasuspharma.com/events/nasus-pharma-to-present-topline-analysis-from-ns002-intranasal-epinephrine-powder-phase-2-single-and-repeat-dose-clinical-study/ 2026-09-22T12:32:11+00:00 https://ir.nasuspharma.com/events/nasus-pharma-presented-clinical-results-at-fourth-annual-aspn-conference/ 2026-09-22T12:41:52+00:00 https://ir.nasuspharma.com/events/h-c-wainwright-27th-annual-global-investment-conference/ 2026-09-22T12:42:25+00:00